NICE recommends new rare inherited bone disorder drug for children
NICE has published further draft guidance as part of its highly specialised technologies programme recommending asfotase alfa (Strensiq, Alexion Pharma UK) for children with a rare, and often fatal genetic condition.
Click on this link for more information.
